Curisium, a Manhattan Beach, CA-based healthcare technology and services company that enables innovative contracting at scale via its blockchain-based platform, raised $3.5M in seed financing.
Backers included Flare Capital Partners, New Enterprise Associates (NEA), Shuttle Fund, Sanofi Ventures, and Green Bay Ventures. In conjunction with the financing, Bill Geary of Flare Capital and Mohamad Makhzoumi of NEA joined the Curisium Board of Directors, and Ruchita Sinha of Sanofi Ventures has been appointed a Board Observer.
Milind Kamkolkar, Chief Data Officer at Sanofi, and Greg Papadopoulos, Venture Partner at NEA and former CTO of Sun Microsystems, have joined Curisium’s inaugural Industry Advisory Board.
Led by Peter Kim, co-founder and CEO, Curisium provides a platform that uses blockchain and secure computation technologies to allow payers, providers, and life science companies to securely engage in innovative, patient-centric value-based contracts.